Fact checked by Nick Blackmer Key Takeaways Cologuard Plus, a new version of the Cologuard colorectal screening test, became ...
Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...
Studies show higher completion rates for mt-sDNA testing and the positive impact of patient navigation in expanding access to underserved and older populations “Exact Sciences’ research at ACG 2025 ...
It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...
Leigh Anne has lived a life showing up for others. As a mom, wife, and teacher, she has dedicated her time to caring for and helping those around her. Because of this, she, like many, put off having a ...
Edgewood, Ky.-based provider network St. Elizabeth Physicians has added additional drop-off locations for patients prescribed the Cologuard test. The new drop-off points are intended to improve ...
June 27--Cologuard, the colorectal cancer screening test by Madison-based Exact Sciences, got a boost this month when a prominent task force dropped its "alternative" designation for the test and ...
Exact Sciences EXAS recently received FDA approval for its next-generation multitarget stool DNA test, Cologuard Plus. This marks a significant advancement for the company in the field of colorectal ...
Modeling data show Cologuard PlusTM test delivers highest life-years gained with fewest number of colonoscopies among noninvasive colorectal cancer (CRC) screening strategies “Exact Sciences is ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250922874822/en/ Horror icon Matthew Lillard is teaming ...
Mark Stenhouse left his executive role at AbbVie to join Exact Sciences because he felt the company was fighting a worthy battle: preventing colorectal cancer. Mr. Stenhouse, now Exact Science’s ...